Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Achieve Life Sciences Inc
(NQ:
ACHV
)
4.510
+0.110 (+2.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Achieve Life Sciences Inc
< Previous
1
2
3
4
Next >
Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment
April 20, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse
March 31, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Achieve Life Sciences Announces Refresh to Board of Directors
March 30, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
March 29, 2023
Topline Data Expected in 2Q 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
March 08, 2023
Topline Data Expected in 2Q 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 03, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
March 02, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
February 07, 2023
Topline Data Expected in 2Q 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation
April 27, 2022
Via
Benzinga
Achieve Life Sciences Announces Granting of New Hire Inducement Award
March 17, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences's Earnings: A Preview
March 15, 2023
Via
Benzinga
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
February 02, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
January 27, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
January 09, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
December 21, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 22, 2022
Via
Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
November 22, 2022
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
Via
Benzinga
Achieve Life Sciences Announces Private Placement of $18.9 Million
November 15, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
November 08, 2022
Phase 2 ORCA-V1 Data Expected in 1H2023
From
Achieve Life Sciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
October 31, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
During Friday, 125 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
During Tuesday's session, 78 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 12, 2022
On Friday, 39 companies reached new 52-week lows.
Via
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 27, 2022
During Monday's session, 77 companies made new 52-week lows.
Via
Benzinga
Achieve Life Sciences: Q1 Earnings Insights
May 12, 2022
Achieve Life Sciences (NASDAQ:ACHV) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From
MicroCap Rodeo
Via
AccessWire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.